Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection - Wikidata - awgldk - TriplyDB

Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection

Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection

http://www.wikidata.org/entity/Q27481055

about

What Are the Prospects for Controlling Hepatitis C?The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds Immune control and failure in HCV infection--tipping the balance.Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection Coinfection with HIV-1 and HCV--a one-two punch.Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.Prospective follow-up of patients with acute hepatitis C virus infection in Brazil.Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence.Adaptive immunity to the hepatitis C virus.Innate and Adaptive Immune Responses in Chronic HCV Infection.Hepatitis C: new clues to better vaccines?Selection of conserved epitopes from hepatitis C virus for pan-populational stimulation of T-cell responses.Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3.Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.Predicting HLA CD4 Immunogenicity in Human Populations.

P2860

Q27488436-CB420316-D010-4788-BA38-3B3511950F82 Q28602408-0D92773A-93B2-4011-A85E-38BACD03C46A Q30532816-F7A8F306-7609-49BC-8704-4ADE4D73CAFA Q34178628-41132903-2C60-4048-A65C-ACA5A60C7A42 Q34642558-57BA21EA-C868-4313-ABEE-47BCD09C637E Q35137038-5B46BCDB-46A2-48FD-8E02-E75A8C868825 Q35404598-45B7E260-1B8C-4CEE-93B3-A94125F49757 Q35665865-E0B85F99-51F2-4E87-88CF-E5AE2CDCBB0D Q35673342-018F4D0E-76F4-4C0E-875A-F840BA336630 Q35679577-2FEBEB62-0EBD-4566-A595-67822DE37437 Q37194029-A3A06DF7-03DB-48AD-ADE8-022E0F3F184A Q37385877-C838A2AF-07B6-4D2D-9D11-FA0BE725164B Q37672414-4609B367-CFF7-42BD-876C-5D531F8E4A95 Q37805839-41CB8285-E3C2-4997-A3F1-CA1C41A3E72F Q41035955-3F7990F7-E237-4554-97C1-22AE89194A42 Q41655694-B6B49029-2308-4394-BD30-6ED459218D47 Q42248450-6A05FA44-221A-4D75-924B-66707A8B22A5 Q42989684-46177EA0-5E25-485B-9C55-5A93BC4F58AA Q50043345-51DCD7FC-9562-4595-9EDD-5D62C00A142A Q55383910-70D8098C-4DE6-4B6F-BD6F-29ECFC1FA598

P2860

Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infection

http://www.wikidata.org/entity/Q27481055

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Immunologic evidence for lack ...... with non genotype 1 infection

@ast

Immunologic evidence for lack ...... with non genotype 1 infection

@en

Immunologic evidence for lack ...... with non genotype 1 infection

@nl

type

label

Immunologic evidence for lack ...... with non genotype 1 infection

@ast

Immunologic evidence for lack ...... with non genotype 1 infection

@en

Immunologic evidence for lack ...... with non genotype 1 infection

@nl

prefLabel

Immunologic evidence for lack ...... with non genotype 1 infection

@ast

Immunologic evidence for lack ...... with non genotype 1 infection

@en

Immunologic evidence for lack ...... with non genotype 1 infection

@nl

P1433

Q27481055-DD506772-DDBE-4BB0-B3D9-EB2DC66778F6

P1476

Q27481055-AB486965-5A9D-44C4-8267-686E26A8B73D

P2093

Q27481055-1BCC0B4F-8C7A-41D5-96A8-5FCCF21A1D4D

Q27481055-39F452E8-186F-4684-B765-E33FD6560C9C

Q27481055-47F6210B-5590-47AA-BCC3-FCB7129EB513

Q27481055-5915C690-A5D3-4CF6-B4CB-0782FBF2C772

Q27481055-6C83EC2E-547B-4A13-B17F-14D4B9525D50

Q27481055-80F01A0E-E42A-4F3E-8189-C386EBC9087D

Q27481055-8B004602-FC43-4360-ABC8-D6146A76F98D

Q27481055-9B188147-414E-4BF0-BC75-7A5D59088D8C

Q27481055-9D84A2FA-394B-4813-B986-1F6EF63703DB

Q27481055-ABDD594A-F093-490E-AD7B-65536BE615AC

P2860

Q27481055-00F5CFE7-321C-437D-BF31-19E51B50C32E

Q27481055-026FF5CE-7C29-4C9C-82AE-F2410A47D614

Q27481055-07AF98FF-693B-4B91-8B37-FC1CDEAE4C55

Q27481055-0A9CAE1D-E2BA-42B8-B3AA-AF1C98F9384A

Q27481055-0FCEBBDD-CEDD-468C-8CDB-6DFA586561FA

Q27481055-18213847-E0DA-40B0-B4F2-C288AD1178BB

Q27481055-1A65277E-0FE2-4F62-8230-8D4A83D8C3CA

Q27481055-1C646316-176A-478C-B759-D46D9DCF1663

Q27481055-1EE8D618-F4EE-42D6-A294-DDCFA542EF95

Q27481055-255DCBEB-AD32-4CAF-9106-CF3F785FE007

P304

Q27481055-4951F20E-13FE-493F-A1B1-7664FE91B976

P31

Q27481055-AE4DAE92-9379-4B36-873E-7F0B8BF733C2

P356

Q27481055-00F95B5C-50F3-429B-9A12-1603F8AFAFB8

P407

Q27481055-45A72A23-D14C-4F0E-A09E-4DD0A3154615

P433

Q27481055-34FFD4D5-D437-46AE-880E-7ACCDB2296B2

P478

Q27481055-47FAD631-B20F-4D03-8E26-CC0E95614BDF

P50

Q27481055-24D6110F-6235-4F5E-957D-E644073F1645

Q27481055-7E70777A-AA6D-4C88-9594-B570F2DE45E6

Q27481055-A6C2B9A0-FC23-47A9-B160-5E665EE28394

Q27481055-FEB8FBB2-7B0F-4F40-BB7D-C36E15D5D05C

P577

Q27481055-917D8F39-7740-4673-8A17-6FBDFC137CB0

P698

Q27481055-7779788E-19B2-4F0F-A398-0F6943FD0EFA

P921

Q27481055-2FF8B19C-8F9F-46D8-8A85-D21A4004DBF3

P932

Q27481055-0F2B3503-F2E4-4E42-8A0B-0F453FB2D6BA

P356

BLOOD-2007-01-069583

P1433

P1476

Immunologic evidence for lack ...... with non genotype 1 infection

@en

P2093

Alysse Wurcel

http://www.w3.org/2001/XMLSchema#string

Andrea M Jones

http://www.w3.org/2001/XMLSchema#string

Andrew Berical

http://www.w3.org/2001/XMLSchema#string

Ansgar W Lohse

http://www.w3.org/2001/XMLSchema#string

Arthur Y Kim

http://www.w3.org/2001/XMLSchema#string

Brian E Nolan

http://www.w3.org/2001/XMLSchema#string

Cory McMahon

http://www.w3.org/2001/XMLSchema#string

Georg M Lauer

http://www.w3.org/2001/XMLSchema#string

Joerg Timm

http://www.w3.org/2001/XMLSchema#string

Lia L Lewis-Ximenez

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical significance of hepatitis C virus genotypes

Dengue: defining protective versus pathologic immunity

Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection

Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.

Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.

Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection

Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection

Outcomes and Treatment of Acute Hepatitis C Virus Infection in a United States Population

Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance

CD8 Epitope Escape and Reversion in Acute HCV Infection

P304

1559-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-01-069583

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Bruce D. Walker

Julian Schulze zur Wiesch

Raymond T Chung

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17475911

http://www.w3.org/2001/XMLSchema#string

P921

P932

1975840

http://www.w3.org/2001/XMLSchema#string